MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Acute Myeloid Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,888 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,888 works in the cohort · of 4,299,418page 11 of 58

Labels cover 3 of 2,888 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,888 of 2,888 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117
Mikkael A. Sekeres, Megan Othus, Alan F. List, Olatoyosi Odenike, Richard M. Stone, Steven D. Gore +12 more
2015· article· en· Blood· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
35
citations
affno abstractunlabeled
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms
Rashmi Kanagal‐Shamanna, Jennelle C. Hodge, Tracy Tucker, Shashi Shetty, Ashwini Yenamandra, Amanda Dixon‐McIver +11 more
2018· review· en· Cancer Genetics· Medicine
distilled prediction:candidate · metaepi_narrow+stsconsensus · none
35
citations
fundno affunlabeled
NUP98-MLL fusion in human acute myeloblastic leukemia
Sophie Kaltenbach, Gwendoline Soler, Carole Barin, Carine Gervais, Olivier Bernard, Virginie Penard‐Lacronique +1 more
2010· article· en· Blood· Medicine
distilled prediction:candidate · noneconsensus · none
34
citations
affunlabeled
Genetic Characterization of ABT-199 Sensitivity in Human AML
Marie-Ève Bordeleau, Richard Bisaillon, Clarisse Thiollier, Jana Krošl, Bernhard Lehnertz, Vincent‐Philippe Lavallée +10 more
2018· article· en· Blood· Medicine
distilled prediction:candidate · noneconsensus · none
34
citations
afffundunlabeled
Chromosomal Instability in Acute Myeloid Leukemia
Mateus de Oliveira Lisboa, Paulo Roberto Slud Brofman, Ana Teresa Schmid-Braz, Aline Rangel‐Pozzo, Sabine Mai
2021· review· en· Cancers· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · none
32
citations
← previousnext →

How this was built: Screen · Findings · About